Literature DB >> 10233950

Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.

F K Yoshimura1, T Wang, M Cankovic.   

Abstract

We previously showed that the 93-bp region between the enhancer and promoter (named DEN for downstream of enhancer) of the long terminal repeat (LTR) of the MCF13 murine leukemia virus is an important determinant of the ability of this virus to induce thymic lymphoma. In this study we observed that DEN plays a role in the regulation of virus replication in the thymus during the preleukemic period. A NF-kappaB site in the DEN region partially contributes to the effect of DEN on both lymphomagenicity and virus replication. To further study the effects of DEN and the NF-kappaB site on viral pathogenicity during the preleukemic period, we examined replication of wild-type and mutant viruses with a deletion of the NF-kappaB site or the entire DEN region in the thymus. Thymic lymphocytes which were infected with wild-type and mutant viruses were predominantly the CD3(-) CD4(+) CD8(+) and CD3(+) CD4(+) CD8(+) cells. The increase in infection by wild-type virus and both mutant viruses of these two subpopulations during the preleukemic period ranged from 9- to 84-fold, depending upon the time point and virus. The major difference between the wild-type and both mutant viruses was the lower rate and lower level of mutant virus replication in these thymic subpopulations. Significant differences in replication between wild-type and both mutant viruses were seen in the CD3(-) CD4(+) CD8(+) and CD3(-) CD4(-) CD8(-) subpopulations, suggesting that these thymic cell types are important targets for viral transformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233950      PMCID: PMC112532     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Nuclear factors that bind two regions important to transcriptional activity of the simian immunodeficiency virus long terminal repeat.

Authors:  S Winandy; B Renjifo; Y Li; N Hopkins
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Oncogenicity of AKR endogenous leukemia viruses.

Authors:  R C Nowinski; E F Hays
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

3.  Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities.

Authors:  H Chen; F K Yoshimura
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

4.  Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation.

Authors:  N Arima; J A Molitor; M R Smith; J H Kim; Y Daitoku; W C Greene
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes.

Authors:  S M Kang; A C Tran; M Grilli; M J Lenardo
Journal:  Science       Date:  1992-06-05       Impact factor: 47.728

Review 6.  The development of functionally responsive T cells.

Authors:  E V Rothenberg
Journal:  Adv Immunol       Date:  1992       Impact factor: 3.543

7.  Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate.

Authors:  D L Kraft; I L Weissman; E K Waller
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

8.  Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.

Authors:  R Hanecak; P K Pattengale; H Fan
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice.

Authors:  K Kawashima; H Ikeda; J W Hartley; E Stockert; W P Rowe; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

10.  Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses.

Authors:  M W Cloyd; J W Hartley; W P Rowe
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  11 in total

1.  Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.

Authors:  Karen Rulli; Jack Lenz; Laura S Levy
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.

Authors:  S K Ghosh; P Roy-Burman; D V Faller
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.

Authors:  F K Yoshimura; T Wang; F Yu; H R Kim; J R Turner
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.

Authors:  Shuhei Sakakibara; Kaori Sakakibara; Giovanna Tosato
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

5.  Sequence analysis of porcine endogenous retrovirus long terminal repeats and identification of transcriptional regulatory regions.

Authors:  Carolyn A Wilson; Sabahat Laeeq; Armin Ritzhaupt; Winston Colon-Moran; Fayth K Yoshimura
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Mink cell focus-forming murine leukemia virus killing of mink cells involves apoptosis and superinfection.

Authors:  F K Yoshimura; T Wang; S Nanua
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus.

Authors:  Yann Moalic; Yannick Blanchard; Hélène Félix; André Jestin
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

8.  Differential cell killing by lymphomagenic murine leukemia viruses occurs independently of p53 activation and mitochondrial damage.

Authors:  Suparna Nanua; Fayth K Yoshimura
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 9.  Tolerance has its limits: how the thymus copes with infection.

Authors:  Cláudio Nunes-Alves; Claudia Nobrega; Samuel M Behar; Margarida Correia-Neves
Journal:  Trends Immunol       Date:  2013-07-16       Impact factor: 16.687

Review 10.  Immune Ecosystem of Virus-Infected Host Tissues.

Authors:  Mohamed Maarouf; Kul Raj Rai; Mohsan Ullah Goraya; Ji-Long Chen
Journal:  Int J Mol Sci       Date:  2018-05-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.